Connect Biopharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $48 | $0 | $1,912 | $24,116 |
Gross Profit | 48 | 1,728 | 23,640 | |
EBITDA | -13,253 | -22,871 | 8,195 | |
EBIT | -13,424 | -23,054 | 7,719 | |
Net Income | -12,899 | -10,272 | -23,217 | 7,649 |
Net Change In Cash | 48 | 0 | 1,912 | 24,116 |
Free Cash Flow | -12,894 | -10,040 | -15,889 | -8,410 |
Cash | 40,632 | 47,709 | 78,232 | 110,174 |
Basic Shares | 55,498 | 55,352 | 55,190 | 55,554 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $26,033 | $0 | $0 | $0 |
Gross Profit | 26,033 | -988 | -1,030 | |
EBITDA | -21,792 | -58,372 | -111,305 | -204,931 |
EBIT | -22,452 | -59,360 | -112,318 | -205,572 |
Net Income | -15,628 | -59,503 | -116,415 | -205,205 |
Net Change In Cash | 26,033 | 0 | 0 | 0 |
Free Cash Flow | -24,362 | -48,224 | -103,551 | -592,455 |
Cash | 78,232 | 105,663 | 80,371 | 268,024 |
Basic Shares | 55,213 | 55,067 | 55,044 | 52,272 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.23 |
2025-03-31 | -$0.19 |
2024-12-31 | -$0.42 |
2023-06-30 | -$0.54 |
